HepatologyVolume 36, Issue S1 p. S1-S2 ArticleFree Access National institutes of health consensus development conference: Management of hepatitis C: 2002 Leonard B. Seeff M.D., Corresponding Author Leonard B. Seeff M.D. [email protected] Division of Digestive Diseases and Nutrition, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MDRm 9A27, Bldg 31, 31 Center Dr, National Institutes of Health, Bethesda, MD 20892. fax: 301–480–7926===Search for more papers by this authorJay H. Hoofnagle, Jay H. Hoofnagle Division of Digestive Diseases and Nutrition, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MDSearch for more papers by this author Leonard B. Seeff M.D., Corresponding Author Leonard B. Seeff M.D. [email protected] Division of Digestive Diseases and Nutrition, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MDRm 9A27, Bldg 31, 31 Center Dr, National Institutes of Health, Bethesda, MD 20892. fax: 301–480–7926===Search for more papers by this authorJay H. Hoofnagle, Jay H. Hoofnagle Division of Digestive Diseases and Nutrition, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MDSearch for more papers by this author First published: 10 February 2006 https://doi.org/10.1002/hep.1840360702Citations: 131AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat No abstract is available for this article. References 1 National Institutes of Health Consensus Development Conference. Management of Hepatitis C. Hepatology 1997; 26: 1S– 156S (suppl 1). 2 Alter MJ, Kruszon-Moran D, Nainan OV, McQuillan GM, Gao F, Moyer LA, Kaslow RA, et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 1999; 341: 556– 562. 3 Armstrong GL, Alter MJ, McQuillan GM, Margolis HS. The past incidence of hepatitis C virus infection: implications for the future burden of chronic liver disease in the United States. Hepatology 2000; 31: 777– 782. 4 Manns MP, McHutchison JG, Gordon SC, Rustgi VK, Shiffman M, Reindollar R, Goodman ZD, et al. Peginterferon alfa-2b plus ribavirin compared with interferonalfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomized trial. Lancet 2001; 358: 958– 965. 5 Liang TJ, Rehermann B, Seeff LB, Hoofnagle JH. Pathogenesis, natura history, treatment and prevention of hepatitis C. Ann Intern Med 2000; 132: 296– 305. Citing Literature Volume36, IssueS1Supplement: National Institutes of Health Consensus Development ConferenceNovember 2002Pages S1-S2 ReferencesRelatedInformation